PHASE III DOUBLE BLIND PLACEBO CONTROLLED RANDOMIZED STUDY ON THE EFFICACY OF URSODEOXYCHOLIC ACID FOR THE TREATMENT OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-001323-64

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary aim of the study is to evaluate the efficacy of UDCA treatment: on delivery week (reducing the rate of prematurity) Both spontaneous and therapeutic deliveries induced before week 37 will be considered preterm.


Critère d'inclusion

  • Intrahepatic Cholestasis of pregnancy

Liens